|
JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC (the 'Company') |
|
|
Legal Entity Identifier: 549300NFZYYFSCD52W53 |
|
|
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 May 2020 |
|
|
GlaxoSmithKline |
5.6% |
|
AstraZeneca |
5.5% |
|
Royal Dutch Shell |
5.1% |
|
British American Tobacco |
4.8% |
|
JPMorgan Smaller Companies Investment Trust |
4.4% |
|
BP |
2.7% |
|
Rio Tinto |
2.7% |
|
RELX |
2.5% |
|
Prudential |
2.5% |
|
Intermediate Capital |
2.2% |
|
Total |
38.1% |
|
Name of contact and telephone number for queries: |
|
|
Paul Ainger 0044 207 742 6524 |
|
|
Name of authorised company official responsible for making this notification: |
|
|
Faith Pengelly 0044 207 742 8627 - Company Secretary |
|
|
Date: 10 June 2020 |
|
|
|
|